Literature DB >> 8462159

Changes in diastolic function during development and correction of chronic LV volume overload produced by mitral regurgitation.

M R Zile1, M Tomita, K Ishihara, K Nakano, J Lindroth, F Spinale, M Swindle, B A Carabello.   

Abstract

BACKGROUND: Mitral regurgitation (MR) causes an augmentation in left ventricular (LV) diastolic function, increasing early diastolic filling rate and decreasing LV stiffness. Whether these changes in diastolic function persist, return to normal, or become abnormal after mitral valve replacement (MVR) is unknown. METHODS AND
RESULTS: Simultaneous LV echocardiography and catheterization studies were performed in six dogs in the baseline state (baseline), 3 months after creation of MR (chronic MR), and 3 months after MVR. Chronic MR caused LV dilation (end-diastolic dimension increased from 4.5 +/- 0.1 cm in baseline to 5.8 +/- 0.1 cm in chronic MR, p < 0.05) and eccentric LV hypertrophy (LV-to-body weight ratio increased from 3.6 +/- 0.2 g/kg in baseline to 4.9 +/- 0.4 g/kg in chronic MR, p < 0.05). Chronic MR caused an increase in LV early diastolic filling rate (peak rate of increase in minor-axis dimension increased from 11 +/- 1 cm/sec in baseline to 18 +/- 1 cm/sec in chronic MR, p < 0.05), did not change the time constant of myocardial relaxation (tau was 31 +/- 4 msec in baseline and 30 +/- 2 msec in chronic MR), and caused a decrease in the modulus of regional chamber stiffness from 7.7 +/- 1.2 in baseline to 2.4 +/- 0.03 in chronic MR, p < 0.05. MVR caused the resolution of LV dilation (end-diastolic dimension returned to normal [4.8 +/- 0.2 cm]), but three months after MVR, regression of LV hypertrophy was incomplete (LV-to-body weight ratio remained elevated [4.4 +/- 0.5 g/kg]). After MVR, LV early diastolic filling rate (8 +/- 1 cm/sec), the relaxation time constant (31 +/- 2 msec), chamber stiffness (7.1 +/- 1.8), myocardial stiffness (11.2 +/- 3.1), and LV end-diastolic pressure (8 +/- 1 mm Hg) returned to normal.
CONCLUSIONS: The enhanced diastolic function seen in chronic MR returned to normal after correction of the chronic volume overload by MVR.

Entities:  

Mesh:

Year:  1993        PMID: 8462159     DOI: 10.1161/01.cir.87.4.1378

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Long-term results of surgical treatment of aortic and mitral regurgitation with enlarged left ventricle.

Authors:  Xian-Min Liu; Hao Wu; Wu-Kui Zhang; Zhi-Wei Xu; Xiu-Fang Xu; Wen-Bin Li; Xu Meng; Bao-Tian Chen; Qi-Wen Zhou; Zi-Fan Zhou
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Effects of sex and gender on adaptation to space: cardiovascular alterations.

Authors:  Steven H Platts; C Noel Bairey Merz; Yael Barr; Qi Fu; Martha Gulati; Richard Hughson; Benjamin D Levine; Roxana Mehran; Nina Stachenfeld; Nanette K Wenger
Journal:  J Womens Health (Larchmt)       Date:  2014-11       Impact factor: 2.681

Review 3.  Fluid dynamics of ventricular filling in heart failure: overlooked problems of RV/LV chamber dilatation.

Authors:  Ares Pasipoularides
Journal:  Hellenic J Cardiol       Date:  2015 Jan-Feb

Review 4.  Evaluation of right and left ventricular diastolic filling.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2013-04-13       Impact factor: 4.132

5.  A Comparison of Phenomenologic Growth Laws for Myocardial Hypertrophy.

Authors:  Colleen M Witzenburg; Jeffrey W Holmes
Journal:  J Elast       Date:  2017-03-01       Impact factor: 2.085

Review 6.  Thin filament remodeling in failing myocardium.

Authors:  Peter VanBuren; Yoko Okada
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.654

7.  Simulated Microgravity and Recovery-Induced Remodeling of the Left and Right Ventricle.

Authors:  Guohui Zhong; Yuheng Li; Hongxing Li; Weijia Sun; Dengchao Cao; Jianwei Li; Dingsheng Zhao; Jinping Song; Xiaoyan Jin; Hailin Song; Xinxin Yuan; Xiaorui Wu; Qi Li; Qing Xu; Guanghan Kan; Hongqing Cao; Shukuan Ling; Yingxian Li
Journal:  Front Physiol       Date:  2016-06-29       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.